Head and neck cancer

From Citizendium
Revision as of 09:57, 31 May 2010 by imported>Robert Badgett (→‎Cetuximab)
Jump to navigation Jump to search

Cause / etiology

Human papillomavirus (HPV) is a risk factor for oropharyngeal cancer.[1]

Treatment

Head and Neck Cancer treatment information from the National Cancer Institute's Physician Data Query


Salivary Gland Cancer treatment information from the National Cancer Institute's Physician Data Query


Cetuximab

Cetuximab chimeric recombinant monoclonal antibody that blocks epidermal growth factor receptor (EGFR).[1]In the major randomized control trial, the percentage of cells that are EGFR positive did not seen to predict the response to cetuximab.[2]

References

  1. 1.0 1.1 Haddad RI, Shin DM (2008). "Recent advances in head and neck cancer.". N Engl J Med 359 (11): 1143-54. DOI:10.1056/NEJMra0707975. PMID 18784104. Research Blogging.
  2. Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al. (2008). "Platinum-based chemotherapy plus cetuximab in head and neck cancer.". N Engl J Med 359 (11): 1116-27. DOI:10.1056/NEJMoa0802656. PMID 18784101. Research Blogging.